Cargando…
Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial
BACKGROUND: Many previous studies have shown the potential therapeutic effect of acupuncture for allergic rhinitis. Most of these studies, however, were limited by the short duration of observations and lack of sham acupuncture as the control group. Our preliminary experiments showed that the use of...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929718/ https://www.ncbi.nlm.nih.gov/pubmed/27363578 http://dx.doi.org/10.1186/s13063-016-1432-z |
_version_ | 1782440642673115136 |
---|---|
author | Sun, Yuxiu Zhao, Hong Ye, Yongming Nie, Wenbin Bai, Wenjing Liu, Jia Li, Sinuo Wang, Fang Han, Mingjuan He, Liyun |
author_facet | Sun, Yuxiu Zhao, Hong Ye, Yongming Nie, Wenbin Bai, Wenjing Liu, Jia Li, Sinuo Wang, Fang Han, Mingjuan He, Liyun |
author_sort | Sun, Yuxiu |
collection | PubMed |
description | BACKGROUND: Many previous studies have shown the potential therapeutic effect of acupuncture for allergic rhinitis. Most of these studies, however, were limited by the short duration of observations and lack of sham acupuncture as the control group. Our preliminary experiments showed that the use of a warm needling achieved a much more persistent effect in the treatment of allergic rhinitis (AR) compared with simple acupuncture therapy. Hence, we have designed a multicenter, randomized controlled trial (RCT) in which the first-line medication loratadine will be used as the control group, and the effect of warm needling therapy will be evaluated through long-term observation. METHODS/DESIGN: The trial is designed as a multicenter, parallel-group, randomized, single-blinded (outcome assessors), non-inferiority trial. A total of 98 patients with persistent AR will be randomly assigned into two groups. Patients in the treatment group will be treated with warm needling at GV14 and acupuncture at EX-HN3, ST2, LI20, EX-HN8, GV23, LU7, LU5 and LI4 three times a week, for a total of 4 weeks. Patients in the control group will be treated with oral loratadine 10 mg/day for 4 weeks. The primary outcome will be the change in the Total Nasal Symptom Score (TNSS) from baseline to that at 6 months after treatment during the follow-up period. The secondary outcomes will include the Total Non-nasal Symptom Score and the Rhinoconjunctivitis Quality of Life Questionnaire, changes in the TNSS from baseline to that at 2 and 4 weeks during treatment, and 3 months after treatment during the follow-up period. Outcomes will be measured at 2 and 4 weeks, and 3 and 6 months after treatment. Any side effects of treatment will be observed and recorded. DISCUSSION: We expect that the study results will provide evidence to determine the effects of warm needling compared with loratadine. Our final goal of the study is to evaluate the difference in the short-term and long-term effects between the two therapeutic methods, especially the long-term effect of warm needling. TRIAL REGISTRATION: ClinicalTrials.gov NCT02339714. Registered on 14 January 2015. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1432-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4929718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-49297182016-07-02 Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial Sun, Yuxiu Zhao, Hong Ye, Yongming Nie, Wenbin Bai, Wenjing Liu, Jia Li, Sinuo Wang, Fang Han, Mingjuan He, Liyun Trials Study Protocol BACKGROUND: Many previous studies have shown the potential therapeutic effect of acupuncture for allergic rhinitis. Most of these studies, however, were limited by the short duration of observations and lack of sham acupuncture as the control group. Our preliminary experiments showed that the use of a warm needling achieved a much more persistent effect in the treatment of allergic rhinitis (AR) compared with simple acupuncture therapy. Hence, we have designed a multicenter, randomized controlled trial (RCT) in which the first-line medication loratadine will be used as the control group, and the effect of warm needling therapy will be evaluated through long-term observation. METHODS/DESIGN: The trial is designed as a multicenter, parallel-group, randomized, single-blinded (outcome assessors), non-inferiority trial. A total of 98 patients with persistent AR will be randomly assigned into two groups. Patients in the treatment group will be treated with warm needling at GV14 and acupuncture at EX-HN3, ST2, LI20, EX-HN8, GV23, LU7, LU5 and LI4 three times a week, for a total of 4 weeks. Patients in the control group will be treated with oral loratadine 10 mg/day for 4 weeks. The primary outcome will be the change in the Total Nasal Symptom Score (TNSS) from baseline to that at 6 months after treatment during the follow-up period. The secondary outcomes will include the Total Non-nasal Symptom Score and the Rhinoconjunctivitis Quality of Life Questionnaire, changes in the TNSS from baseline to that at 2 and 4 weeks during treatment, and 3 months after treatment during the follow-up period. Outcomes will be measured at 2 and 4 weeks, and 3 and 6 months after treatment. Any side effects of treatment will be observed and recorded. DISCUSSION: We expect that the study results will provide evidence to determine the effects of warm needling compared with loratadine. Our final goal of the study is to evaluate the difference in the short-term and long-term effects between the two therapeutic methods, especially the long-term effect of warm needling. TRIAL REGISTRATION: ClinicalTrials.gov NCT02339714. Registered on 14 January 2015. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13063-016-1432-z) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-30 /pmc/articles/PMC4929718/ /pubmed/27363578 http://dx.doi.org/10.1186/s13063-016-1432-z Text en © Sun et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Study Protocol Sun, Yuxiu Zhao, Hong Ye, Yongming Nie, Wenbin Bai, Wenjing Liu, Jia Li, Sinuo Wang, Fang Han, Mingjuan He, Liyun Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial |
title | Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial |
title_full | Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial |
title_fullStr | Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial |
title_full_unstemmed | Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial |
title_short | Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial |
title_sort | efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929718/ https://www.ncbi.nlm.nih.gov/pubmed/27363578 http://dx.doi.org/10.1186/s13063-016-1432-z |
work_keys_str_mv | AT sunyuxiu efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT zhaohong efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT yeyongming efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT niewenbin efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT baiwenjing efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT liujia efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT lisinuo efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT wangfang efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT hanmingjuan efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial AT heliyun efficacyandsafetyofusingawarmingneedleforpersistentallergicrhinitisstudyprotocolforarandomizedcontrolledtrial |